Which of the following is NOT a common side effect of aromatase inhibitors?

Prepare for the ONS Chemotherapy Immunotherapy Certificate Exam with our comprehensive study tools, including flashcards and multiple choice questions. Each question offers hints and thorough explanations to enhance your understanding and readiness!

Aromatase inhibitors are commonly used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. These medications work by reducing estrogen levels in the body, which can lead to various side effects.

Hot flashes and increased sweating are well-recognized side effects associated with aromatase inhibitors due to the lower estrogen levels, which can affect temperature regulation and cause vasomotor symptoms. Dizziness can also occur, potentially due to hormonal changes or other underlying factors.

Memory loss, however, is not typically recognized as a common side effect of aromatase inhibitors. While some patients undergoing cancer treatment may report cognitive changes (often referred to as "chemo brain"), this phenomenon is more complex and not directly linked to aromatase inhibitors themselves. Therefore, identifying memory loss as a non-common side effect helps clarify that it is not a direct consequence of these medications.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy